MTOR and acute myeloid leukemia: They found that palmitoylated proteins on AML‐derived EVs activate TLR2 signaling, leading to downstream Akt/mTOR pathway activation, crucial for MDSC proliferation and immunosuppressive function in the AML microenvironment.